Investor Relations

Hexoskin is a private company dedicated to revolutionizing health monitoring and diagnostics through innovative technology. Our wearable sensors, clinical software, and AI products are designed to provide answers to clinical questions.

If you're a qualified investor you can contact us at

Clinical Research & Digital Biomarker Development

Hexoskin provides solutions for clinical research and digital biomarker development for biopharma companies, research hospitals and academia, covering a wide range of applications, from cardiac and respiratory diseases to mental health and rare diseases.

The US digital biomarkers market is forecasted to grow by 20.5% annually between 2023 and 2030 (Grand View Research) to over $5B annually.

AI Diagnostics

Hexoskin is developing cutting-edge clinical algorithms for automated diagnosis, with a focus on cardiac and respiratory symptoms. Our goal is to increase access to care, 24/7, anywhere on the planet.

The foundation of any AI system is data infrastructure. Hexoskin has built a unique data infrastructure to collect continuous, high resolution physiological data in real-life settings.

Hexoskin has been collecting data for over 10 years, and is curating one of the largest database of physiological data in the world.

Space Medicine

Hexoskin has been working with space agencies since 2011 to develop monitoring solutions for space medicine research. Its Astroskin technology has been part of the International Space Station life science research equipment since January 2019, and the company has shipped 17 space payloads since.


Hexoskin is backed by dozens of successful investors, including tech veterans who previously worked at companies like Google, Apple, Microsoft, Novartis.

Together, we can unlock the full potential of wearable health technology and transform the way we monitor and manage our health. Join us on this journey and help us make a meaningful impact on the lives of millions.

For more information on investment opportunities and how you can become a part of Hexoskin's success story, please contact our Investor Relations team at